https://www.selleckchem.com/pr....oducts/wnt-agonist-1
One-way and probabilistic sensitivity analysis (PSA) were also conducted. After 1 year, the calculated incremental cost-effectiveness ratio (ICER) for group 1 versus group 2 was -$4,373 with group 1 (dHACA) being dominant over group 2 (SOC). PSA demonstrated that group 1 had 69.2% lower cost values with increased positive incremental effectiveness for 94.9% of values. A willingness to pay (WTP) curve showed that about 92% of interventions were cost effective for group 1 when $50,000 was paid. The results of this study demonstrated
Like
Comment
Share
